Hepatocellular Carcinoma Risk, Outcomes, and Screening After Hepatitis C Eradication

by Roberta D’Ambrosio, George N. Ioannou
Published 2021-09-01

Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis[S]

by George N. Ioannou, W. Geoffrey Haigh, David Thorning, Christopher Savard
Published 2013-05-01

Distinguishing NASH Histological Severity Using a Multiplatform Metabolomics Approach

by George N. Ioannou, G. A. Nagana Gowda, Danijel Djukovic, Daniel Raftery
Published 2020-04-01

Eradication of Hepatitis C Virus Is Associated With Reduction in Hematologic Malignancies: Major Differences Between Interferon and Direct‐Acting Antivirals

by George N. Ioannou, Pamela K. Green, Kristin Berry, Solomon A. Graf
Published 2019-08-01

Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis.

by George N Ioannou, Pamela Green, Elliott Lowy, Elijah J Mun, Kristin Berry
Published 2018-01-01

Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease.

by Silvia Cermelli, Anna Ruggieri, Jorge A Marrero, George N Ioannou, Laura Beretta
Published 2011-01-01

Incidence of and Risk Factors for Hepatic Encephalopathy in a Population‐Based Cohort of Americans With Cirrhosis

by Elliot B. Tapper, James B. Henderson, Neehar D. Parikh, George N. Ioannou, Anna S. Lok
Published 2019-11-01

Practice facilitation to implement alcohol-related care in Veterans Health Administration liver clinics: a study protocol

by Madeline C. Frost, George N. Ioannou, Judith I. Tsui, E. Jennifer Edelman, Bryan J. Weiner, Olivia V. Fletcher, Emily C. Williams
Published 2020-07-01

Cholesterol Crystals in Hepatocyte Lipid Droplets Are Strongly Associated With Human Nonalcoholic Steatohepatitis

by George N. Ioannou, Charles S. Landis, Ga‐Young Jin, W. Geoffrey Haigh, Geoffrey C. Farrell, Rahul Kuver, Sum P. Lee, Christopher Savard
Published 2019-06-01

Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH

by George N. Ioannou, Derrick M. Van Rooyen, Christopher Savard, W. Geoffrey Haigh, Matthew M. Yeh, Narci C. Teoh, Geoffrey C. Farrell
Published 2015-02-01

Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH[S]

by George N. Ioannou, Savitha Subramanian, Alan Chait, W. Geoffrey Haigh, Matthew M. Yeh, Geoffrey C. Farrell, Sum P. Lee, Christopher Savard
Published 2017-06-01

Alcohol Use and Long‐Term Outcomes Among U.S. Veterans Who Received Direct‐Acting Antivirals for Hepatitis C Treatment

by Nicole J. Kim, Meredith Pearson, Philip Vutien, Feng Su, Andrew M. Moon, Kristin Berry, Pamela K. Green, Emily C. Williams, George N. Ioannou
Published 2020-02-01

Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid.

by Wonbeak Yoo, Donjeta Gjuka, Heather L Stevenson, Xiaoling Song, Hong Shen, Suk Young Yoo, Jing Wang, Michael Fallon, George N Ioannou, Stephen A Harrison, Laura Beretta
Published 2017-01-01

Machine learning models to predict disease progression among veterans with hepatitis C virus.

by Monica A Konerman, Lauren A Beste, Tony Van, Boang Liu, Xuefei Zhang, Ji Zhu, Sameer D Saini, Grace L Su, Brahmajee K Nallamothu, George N Ioannou, Akbar K Waljee
Published 2019-01-01

Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice

by Savitha Subramanian, Leela Goodspeed, Shari Wang, Jinkyu Kim, Lixia Zeng, George N. Ioannou, W. Geoffrey Haigh, Matthew M. Yeh, Kris V. Kowdley, Kevin D. O'Brien, Subramaniam Pennathur, Alan Chait
Published 2011-09-01

Eliciting patient views on the allocation of limited healthcare resources: a deliberation on hepatitis C treatment in the Veterans Health Administration

by Akbar K. Waljee, Kerry A. Ryan, Chris D. Krenz, George N. Ioannou, Lauren A. Beste, Monica A. Tincopa, Sameer D. Saini, Grace L. Su, Maria E. Arasim, Patti T. Roman, Brahmajee K. Nallamothu, Raymond De Vries
Published 2020-05-01

Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling

by Jessie Qiaoyi Liang, Narcissus Teoh, Lixia Xu, Sharon Pok, Xiangchun Li, Eagle S. H. Chu, Jonathan Chiu, Ling Dong, Evi Arfianti, W. Geoffrey Haigh, Matthew M. Yeh, George N. Ioannou, Joseph J. Y. Sung, Geoffrey Farrell, Jun Yu
Published 2018-10-01